Abstract
We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to azithromycin and doxycycline in 6 posttreatment and 4 pretreatment samples.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Topical
-
Adult
-
Anti-Bacterial Agents / therapeutic use*
-
Azithromycin / therapeutic use*
-
Child
-
Child, Preschool
-
Chlamydia trachomatis / drug effects*
-
Chlamydia trachomatis / genetics
-
Cycloheximide / pharmacology
-
Drug Resistance, Microbial / genetics*
-
Ethiopia / epidemiology
-
Eye Diseases / drug therapy
-
Eye Diseases / epidemiology
-
Eye Diseases / microbiology*
-
Female
-
Genetic Predisposition to Disease
-
Humans
-
Infant
-
Male
-
Pregnancy
-
Pregnancy Complications, Infectious / drug therapy
-
Prevalence
Substances
-
Anti-Bacterial Agents
-
Azithromycin
-
Cycloheximide